HeartSciences (HSCSW) Receivables (2022 - 2025)
HeartSciences' (HSCSW) quarterly Receivables came in at $4350.0 in Q4 2025, down 70.41% quarter-over-quarter from $14700.0 in Q1 2024.
Powered by 
Analysis
HeartSciences (HSCSW) Receivables (2022 - 2025) Analysis & Trends
HeartSciences (HSCSW) has reported Receivables for 4 consecutive years, with $4350.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Receivables changed N/A year-over-year to $4350.0; the trailing twelve-month figure through Dec 2025 stood at $4350.0 (changed N/A YoY), and the FY2025 full-year result was $4350.0, changed N/A from the prior year.
- Receivables fell to $4350.0 in Q4 2025 per HSCSW's latest filing, from $14700.0 in the prior quarter.
- Across five years, Receivables topped out at $14700.0 in Q1 2024 and bottomed at $2321.0 in Q2 2022.
- Historically, Receivables has averaged $6317.8 across 4 years, with a median of $4125.0 in 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.80 Bn | 27.69 Bn | 2.18 Bn | 4.66 Bn |
| 2 | Lantheus Holdings | 6.58 Bn | 5.98 Bn | 241.86 Mn | 352.89 Mn |
| 3 | Heartflow | 4.13 Bn | 3.75 Bn | 53.19 Mn | 43.27 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 146.80 Mn |
| 5 | Butterfly Network | 1.98 Bn | 1.85 Bn | 23.29 Mn | 34.55 Mn |
| 6 | Ceribell | 924.18 Mn | 794.92 Mn | 25.94 Mn | 18.19 Mn |
| 7 | QuidelOrtho | 878.34 Mn | 754.94 Mn | - | 470.30 Mn |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | 144.70 Mn |
| 9 | Prenetics Global | 338.80 Mn | 279.75 Mn | 30.20 Mn | -1.82 Mn |
| 10 | HeartSciences | 184,567.09 | -1.52 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4,350.00 |
| Jan 31, 2024 | 14,700.00 |
| Oct 31, 2023 | 3,900.00 |
| Apr 30, 2022 | 2,321.00 |